Coherus BioSciences has completed the sale of its Udenyca (pegfilgrastim-cbqv) franchise to Intas Pharmaceuticals under an ...

Recursion Pharmaceuticals' stock jumped after the FDA announced plans to replace the use of animals in drug testing. Recursion is a leader in AI-powered drug discovery and development. It remains ...

“We're going to be announcing very shortly a major tariff on pharmaceuticals. And when they hear that, they will leave China,” Trump said Tuesday at a Republican fundraiser. The measure will ...

Trump said he wants to bring more drug manufacturing to the U.S. At a political fundraising dinner on Tuesday night, President Donald Trump said he plans to announce tariffs on pharmaceuticals soon.

“Major” tariffs on pharmaceutical imports are coming soon, President Donald Trump says, pledging that they’d help bring drug manufacturing back to the US while lamenting that other countries ...

President Donald Trump said Tuesday that his administration will soon impose tariffs on pharmaceuticals coming from foreign countries, predicting drug companies will move their operations to the U.S..

Australian drugmakers were scrambling to make sense of US President Donald Trump saying he would announce a “major” tariff on pharmaceuticals in an expansion of his damaging trade war that ...

Continuing his economic onslaught, US President Donald Trump said on Tuesday that Washington is planning to announce a "major" tariff on pharmaceutical imports soon. India's pharmaceuticals sector ...

April 9 (UPI) --Pharmaceuticals produced in China could become costlier after President Donald Trump announced his intention to impose a "major tariff on pharmaceuticals." Trump said he would ...

President Trump said Tuesday his administration soon would announce “major” tariffs on pharmaceuticals, adding to the tariffs he has already imposed on most goods entering the United States ...

U.S. pharmaceutical giants face significant pressure in pre-market trading following President Trump’s announcement of an impending “major tariff on pharmaceuticals.” Pfizer and AbbVie ...

In today’s news, Australia’s sharemarket plunges again, CSL slumps as pharmaceuticals await a “major” tariff from Donald Trump, and a $1.3 trillion bond trade unwinds. $32b wiped from ASX ...